STEPHANIE WHITE: Open Payments
NPI 1497213185 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 21 payments from 10 companies in 2025. Trend: 2023 $266 · 2024 $931 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 8 | $195 |
| PFIZER INC. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: VELPHORO, LEQVIO, MYFEMBREE, ONPATTRO, PREVNAR 20, Assure WCD, REPATHA, VYNDAQEL.
Industry payments across KY — which companies pay providers there.
